Kratom (Mitragyna speciosa) has been a popular botanical supplement for years, and one of its naturally occurring compounds, 7‑Hydroxymitragynine (often called 7OH or 7‑OH), is one of the most potent and controversial ingredients associated with the plant. Unlike kratom leaf itself, which remains mostly unregulated at the federal level, 7OH is attracting increasing scrutiny from federal and state officials due to its powerful opioid‑like effects.
This guide explains the current legal status of 7OH, how it differs from kratom leaf, the state landscape, and what consumers and retailers should know in 2026.
Federal Law: Still Uncontrolled But Under Strong Scrutiny
At the federal level, kratom and its alkaloids (including mitragynine and 7OH) are not currently scheduled controlled substances, meaning they aren’t listed as illegal drugs under the federal Controlled Substances Act.
However, that status is rapidly changing, especially for 7OH:
- In 2025, the FDA officially recommended that the U.S. Drug Enforcement Administration (DEA) classify certain 7‑hydroxymitragynine products as controlled substances due to their opioid‑like effects and potential for abuse.
- The FDA has also issued warnings to companies selling concentrated 7OH products marketed as supplements or treatments, emphasizing that these products are not approved and may be unsafe.
The DEA has not yet finalized any scheduling decision, but federal regulators are clearly signaling a move toward control of concentrated 7OH. Especially synthetically enhanced versions.
Key takeaway: Kratom leaf remains unscheduled federally, but 7OH, particularly in concentrated or synthetic form, is under active review for tighter federal control.
Why is 7OH Treated Differently Than Kratom Leaf?
Kratom products vary widely from raw leaf and powders to extracts, tablets, drinks, and more. While most natural kratom leaf contains only tiny amounts of 7OH, some products are formulated to boost 7OH content. These higher‑potency products have raised red flags with regulators.
Here’s the distinction:
- Kratom leaf products: Often sold as botanical supplements and subject to FDA warnings, but not banned federally.
- Concentrated or semi‑synthetic 7OH products: Targeted by the FDA and state authorities because of their opioid‑like potency and safety concerns.
Because of this difference, legal treatment of 7OH may be very different from that of “regular” kratom.
State Laws: A Patchwork of Rules
Across the U.S., kratom and 7OH legality varies widely. Some states ban kratom entirely, others regulate it, and some focus specifically on products with high levels of 7OH or synthetic enhancements.
States Where Kratom and 7OH Are Banned
A handful of states have outlawed kratom and its alkaloids, meaning possession, sale, and use are prohibited:
- Alabama
- Arkansas
- Indiana
- Rhode Island
- Vermont
- Wisconsin
In these places, kratom and likely any concentrated 7OH products are illegal. Similar to how other controlled substances are treated at the state level.
Read: Is 7OH Legal in Georgia?
States and Local Bans or Restrictions
Even in states where kratom isn’t banned statewide, local governments sometimes impose their own bans or restrictions:
- Pike County, Illinois, recently passed an ordinance banning the sale of kratom and 7OH products.
- Other cities and counties have enacted similar bans as part of public health efforts.
This means you may be able to legally possess kratom or 7OH in one town but not in another, even within the same state.
States With Consumer Protection or Regulatory Regimes
Many states have adopted Kratom Consumer Protection Acts (KCPA) or similar regulations that:
- Require age verification (often 18 + or 21 +)
- Mandate accurate labeling and lab testing
- Set quality standards for purity and contaminant limits
- Prohibit adulterants and unsafe additives
These laws aim to regulate the kratom market rather than ban it outright and are increasingly common across multiple jurisdictions. However, not all such laws address 7OH specifically, and those that do may impose different limits or restrictions than for mitragynine.
FDA and Public Safety Concerns
Federal agencies, especially the FDA, have repeatedly emphasized that:
- Kratom and 7OH are not approved for medical use or as dietary supplements.
- Some kratom and 7OH products have been linked to serious side effects and safety issues.
- The FDA is focusing its enforcement on highly concentrated or synthetically enhanced 7OH products, not natural kratom leaf.
Even where products remain technically legal, the FDA’s stance affects enforcement and regulatory actions, such as warning letters, import alerts, and public health advisories.
What This Means for You
Here’s how to navigate this evolving environment:
1. Know Your Location’s Laws
Federal status is only one part of the picture, state and local rules matter most. Always check current laws before buying, selling, or consuming 7OH products.
2. Distinguish Product Types
Natural kratom leaf, low‑potency extracts, and concentrated 7OH products may be treated differently by regulators. Higher‑potency 7OH formulas face greater legal risk.
3. Look for Evidence of Compliance
Where allowed, products should have Certificates of Analysis (COAs) showing tested levels of alkaloids and contaminants, helping demonstrate transparency and safety.
4. Expect Continued Changes
Legal scrutiny of 7OH is intensifying both at the federal and state levels. What’s allowed today may change in 2026 or beyond, so staying informed and consulting legal resources regularly is essential.
Conclusion
The legal situation for 7‑hydroxymitragynine is complicated and evolving. While traditional kratom leaf remains not scheduled at the federal level, regulatory pressure on concentrated or synthetic 7OH products is growing significantly. Individual states and local governments approach these substances differently, from outright bans to regulated frameworks.
If you’re a consumer or retailer, your best strategy is to stay educated about the latest laws in your area, ensure products are properly tested and labeled, and be cautious about high‑potency or unfamiliar products. Laws can change quickly, especially when public health concerns are involved.
Legal Disclaimer
This article is for informational purposes only and does not constitute legal advice. Laws and regulations can change frequently. Always consult official government sources or legal professionals for the most current and specific guidance.
About the Author
